3,4-dimethoxybenzyl isothiocyanate enhances doxorubicin efficacy in LoVoDX doxorubicin-resistant colon cancer and attenuates its toxicity in vivo-Science-Chemical Encyclopedia-lookchem

3,4-dimethoxybenzyl isothiocyanate enhances doxorubicin efficacy in LoVoDX doxorubicin-resistant colon cancer and attenuates its toxicity in vivo
Add time:07/12/2019 Source:sciencedirect.com

AimsThe aim of the study was to evaluate the potential of naturally occurring isothiocyanates and doxorubicin in combined treatment of doxorubicin-resistant colon cancer. Doxorubicin is a cytostatic commonly used to treat many different types of cancer but its usage is often abrogated by severe side-effects and drug-induced resistance.

We also recommend Trading Suppliers and Manufacturers of N-(3,4-dimethoxybenzyl)-4-methylbenzenesulfonamide (cas 65588-60-5). Pls Click Website Link as below: cas 65588-60-5 suppliers

Prev:Evaluation of the structural, electronic, topological and vibrational properties of N-(3,4-dimethoxybenzyl)-hexadecanamide isolated from Maca (Lepidium meyenii) using different spectroscopic techniques
Next: 2-Imino-(3,4-dimethoxybenzyl) ethanesulfonic acid Schiff base anchored silver nanocomplex mediated by sugarcane juice and their antibacterial activities)

Click to view details

Encyclopedia